Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2025 Oct 25.
Published in final edited form as: J Appl Physiol (1985). 2025 Sep 23;139(5):1101–1111. doi: 10.1152/japplphysiol.00328.2025

Acute cardiovascular and cerebral blood flow responses to high frequency, low amplitude vibration on the neck

Viet Q Dinh 1,*, Malinda Hansen 2,*, K Austin Davis 1, Lindsey Peralez 1, Caroline A Rickards 1
PMCID: PMC12551627  NIHMSID: NIHMS2113965  PMID: 40987537

Abstract

Local muscle vibration (LMV) is a potential therapeutic approach to treat symptoms related to stroke by improving muscle function and blood flow. In this study, we assessed the acute cardiovascular and cerebral blood flow responses to LMV when applied to the anterior neck muscles in young and healthy participants. We hypothesized that LMV would elicit minimal acute cardiovascular responses. Ten human participants (5 male, 5 female) underwent LMV on both sides of their neck for 5-min each. Arterial pressure, middle cerebral artery blood velocity (MCAv), and common carotid artery (CCA) blood flow were measured continuously. There was no effect of LMV on mean arterial pressure (RIGHT, Baseline: 96.9±4.9 mmHg vs. LMV: 97.8±5.7 mmHg vs. Recovery: 98.2±4.6 mmHg, P=0.25; LEFT, Baseline: 96.0±7.8 mmHg vs. LMV: 97.0±7.7 mmHg vs. Recovery: 97.9±7.5 mmHg; P=0.23) or MCAv (RIGHT, Baseline: 61.4±10.5 cm/s vs. LMV: 62.0±10.7 cm/s vs. Recovery: 59.3±9.7 cm/s; P=0.15; LEFT, Baseline: 59.9±10.2 cm/s vs. LMV: 60.6±10.8 cm/s vs. Recovery: 58.4±10.2 cm/s; P=0.20). CCA diameter increased slightly with LMV on both sides of the neck (RIGHT, Baseline: 6.2±0.6 mm vs. LMV: 6.3±0.7 mm, P=0.03; LEFT, Baseline: 6.4±0.5 mm vs. LMV: 6.5±0.5 mm, P=0.03). However, this did not affect CCA blood flow (RIGHT, Baseline: 330.7±68.5 ml/min vs. LMV: 324.7±57.6 ml/min, P=0.59; LEFT, Baseline: 358.1±67.5 vs. LMV: 344.2±78.3 ml/min, P=0.30). These data provide evidence that a single acute session of LMV does not affect key cardiovascular parameters in young and healthy participants.

Keywords: local muscle vibration, therapy, vasodilation, blood flow, stroke

Graphical Abstract

graphic file with name nihms-2113965-f0001.jpg

NEW & NOTEWORTHY

Local muscle vibration (LMV) is a potential therapeutic approach to treat symptoms related to stroke by improving muscle function and blood flow. Our findings demonstrate that a single session of LMV has minimal impact on cardiovascular and cerebral blood flow responses when applied to the neck in healthy and young participants. Additional follow-up studies in older healthy participants may be needed to further verify this safety profile prior to application of LMV in stroke patients.

INTRODUCTION

Local and whole-body vibration have been utilized in the clinical setting since the 1880s when the French neurologist Jean-Martin Charcot noticed that patients suffering from Parkinson’s disease experienced a reduction in their resting tremor after a train carriage ride, or after horseback riding1. Local muscle vibration (LMV) has since gained popularity, with growing evidence that it improves muscle activation and peak muscle torque after anterior cruciate ligament reconstruction, functional and gait parameters in the elderly, muscle recovery following exercise, blood flow distal to local muscle vibration, and it can also reduce arthrogenic inhibition of muscles2–10.

After a stroke, individuals often have residual deficits with speaking and difficulty swallowing, with varying timeframes of neurogenesis and plasticity in the recovery phase11. LMV could be used as a rehabilitative tool to improve neural patterning and function of swallowing in the acute post-stroke setting. To date, however, LMV has only been evaluated on the posterior neck musculature. In a systematic review of posterior neck muscle vibration and spatial orientation, Jamal et al. assessed data from 1522 participants (both healthy individuals and individuals with vascular impairments) with local vibration (either bilateral or unilateral) applied to the dorsal neck muscles, paravertebral or paraspinal neck muscles12. They reported that local vibration applied to these regions induced an illusory effect of movement in the opposite direction of the vibratory stimulus. Furthermore, the longer the duration of vibration, the longer the proprioception was altered, with most participants reporting no sustained effects once the vibration was removed12. A number of studies have demonstrated that local vibrations at higher frequencies (40–120 Hz) and lower amplitudes (0.1–3.0 mm) have a potent effect on the muscle spindles, alpha motor neuron firing thresholds, and corticospinal tracts to create increased motor unit recruitment (i.e., neuromuscular reeducation), as well as increased blood velocity in the lower extremities13–25; these studies were conducted in both healthy individuals and individuals with vascular impairments.

To our knowledge, no study has evaluated the cardiovascular effects of LMV on the small musculature of the anterior neck. Previous studies on LMV have reported that high frequency vibration (ranging from 30 Hz to 50 Hz) can increase skin blood flow when applied to the forearm or to the calf muscles18,26. Higher frequency vibration (150–250 Hz) at low amplitude also induced skin vasodilation, indexed by changes in skin temperature, when applied to the arms, legs, trunk, hands, and face in men and women aged 20–70 years27. Furthermore, Needs et al. demonstrated that both 38 Hz and 48 Hz vibration on the calf increases popliteal blood flow without affecting heart rate28. In addition to the effects on blood flow, some studies have investigated the potential use of high frequency vibration (47 Hz) on tissue healing. Arashi et al. report that local vibration therapy for 7 days in older adults with Stage I pressure ulcers led to a greater percentage of ulcers being healed, as well as a greater healing rate29. Using the same vibration device, Syabariyah et al. show that local vibration wound therapy combined with standard wound treatment enhanced the healing of Wagner grade I–III diabetic neuropathic foot ulcers, compared to that of standard wound treatment alone30. These findings were associated with higher circulating nitric oxide, but no measures of blood flow were made. Collectively, these studies provide evidence for the potential use of LMV as a treatment for tissue injuries, potentially due to increases in blood flow.

The safety of LMV on the anterior neck in a young and healthy cohort with no vascular impairments must first be demonstrated before any further studies can be undertaken for the treatment of stroke, as the carotid arteries and jugular veins are in close proximity to the small anterior musculature. Additionally, local vibration can induce mechanical dilation of the blood vessels and increase blood velocity, most likely through shear forces and release of nitric oxide2,28,31–34. In evaluating the safety of LMV on the neck, key cardiovascular responses, such as heart rate and arterial pressure, must also be assessed due to the proximity of the probe to the carotid arterial baroreceptors. As prior studies have demonstrated the potential for LMV to increase blood flow via vasodilatory mechanisms, we anticipate that blood flow to the brain may increase in response to LMV in a young and healthy population.

Therefore, the aim of this study was to examine the safety of LMV on the smaller muscles of the anterior neck in young and healthy participants, with a specific focus on blood flow responses within the major blood vessels entering the brain (extracranial) and within the brain (intracranial), in addition to other key cardiovascular parameters. We hypothesized that in young and healthy participants, LMV would elicit a local vasodilation and increases in blood flow in the common carotid artery, with only minimal changes in other key cardiovascular responses.

METHODS

Ethical Approval

The experimental protocol was reviewed and approved by the North Texas Regional Institutional Review Board (Protocol no. 2046872–7; IRB #2023–042), and performed at The University of North Texas Health Science Center at Fort Worth.

Participants & Medical Screening

Healthy human participants aged 18–40 years were recruited. Participants visited the laboratory for one familiarization session and one experimental session, separated by at least 24 hours. Prior to both sessions, participants were asked to abstain from exercise, alcohol, caffeine, dietary supplements, and all medications (prescription and non-prescription) for 24 hours, and food for 2 hours prior to the session. During the familiarization session, participants were informed on the purpose, design, and risks of the study, and provided written, informed consent before enrollment. Participants then completed medical history questionnaires, and seated and standing 12-lead ECG and blood pressure measurements, and participants with a menstrual cycle completed a pregnancy test to confirm they were not pregnant; all of these findings were sent for physician review prior to the experimental session. Participants were excluded if they had any history of cardiovascular, respiratory, endocrine, or neurological diseases. At the end of this session, both left and right common carotid arteries were visualized to confirm the absence of plaques or other vascular abnormalities, and to ensure adequate measurements could be made of arterial diameter and velocity. Participants then experienced a brief (~1-min) period with the activated LMV probe on their neck to familiarize them with the sensation. Participants confirmed that they could tolerate this stimulus and agreed to continue participating in the subsequent experimental protocol.

Experimental Protocol

At least 24 hours following the familiarization session, participants returned to the laboratory for the experimental session. Participants with a menstrual cycle completed the experimental session during the early follicular phase of their menstrual cycle (days 1–4 based on self-report); these participants also completed a second urine pregnancy test to confirm they were still not pregnant.

Local Muscle Vibration (LMV)

LMV was achieved via a small percussive device with a pen effector tip 0.5 × 0.5 × 0.5 inch in size (Sola Gratia, LLC, Fort Worth, Texas, USA; see images in figure 1) placed on the superior aspect of the lateral edge of the hyoid bone. The device vibrated at a frequency of 80 Hz and an amplitude of 0.2 mm, with a maximum of 2.5 pounds of pressure per square inch (PSI; built-in threshold of pressure of the device).

Figure 1.

Figure 1

The Local Muscle Vibration (LMV) percussive device (A and B) and its placement immediately lateral and superior to the cricoid cartilage of the larynx (C).

Instrumentation

All participants were seated upright on a chair with their knees at a ~90° angle, and their feet placed flat on the ground. Participants were then instrumented for continuous measurement of heart rate via ECG in a lead II configuration (shielded leads, cable, and amplifier; AD Instruments, Dunedin, New Zealand), and beat-to-beat arterial pressure (and calculation of stroke volume) via finger photoplethysmography (Finometer™, Finapres Medical Systems BV, Amsterdam, The Netherlands). Common carotid artery (CCA) diameter and velocity were recorded via duplex Doppler ultrasound (Terason uSmart 3300, Teratech Corporation, Burlington, MA, USA) using a 15 MHz linear probe (15L4 Smart Mark) 1–2 cm distal to the carotid bulb, with an insonation angle of 60°. Care was taken so that the ultrasound probe did not interfere with the positioning of the LMV device. Intracranial cerebral blood flow was indexed by measuring middle cerebral artery blood velocity (MCAv) through the temporal windows via transcranial Doppler ultrasound probes (ST3, Spencer Technologies, Seattle, WA, USA) placed on the left and right side of the head. The MCA was confirmed by assessment of the velocity at rest, the insonation depth (~50 mm), the velocity waveform shape, the directionality of blood flow towards the probe, and the sound of the signal (relative to other vessels). Absolute concentrations of oxyhemoglobin (O2Hb) and deoxyhemoglobin (dHb) from the right frontal lobe were measured via near-infrared spectroscopy (NIRS; OxiplexTS, ISS Inc., Champaign, IL, USA) for the subsequent calculation of cerebral tissue oxygenation (ScO2; [(O2Hb/(O2Hb+dHb))×100]). Respiratory rate and end-tidal CO2 (PETCO2) were measured via an oral nasal cannula connected to a gas analyzer (ML206 Gas Analyzer, AD Instruments, Dunedin, New Zealand).

Protocol

After instrumentation, baseline measurements were recorded for 5 min. The LMV probe was then placed on one side of the participant’s neck for 5 min (side order was randomized for each participant). Ultrasound measurements of the CCA were made on the same side as the LMV. These measurements were followed by a 5-min recovery period. Once all hemodynamic measurements returned to baseline values, the same procedure was repeated on the other side of the neck. Participants were continuously monitored during the entire protocol, and the experiment was terminated if the participant reported having any pain or discomfort.

Data Analysis

Continuous measurements of ECG, arterial pressure, MCAv, and ScO2 were recorded at 1000 Hz (LabChart and PowerLab, AD Instruments, Dunedin, New Zealand), and imported into specialized software for analysis (WinCPRS, Absolute Aliens Oy, Turku, Finland). R-waves were detected from the ECG signal and used to determine heart rate and define cardiac cycles for beat-to-beat analysis. Systolic arterial pressure (SAP), diastolic arterial pressure (DAP), and mean arterial pressure (MAP) were calculated from the arterial pressure waveform. Cardiac output was calculated as a product of stroke volume and heart rate. Systemic vascular conductance was calculated by dividing cardiac output by MAP.

CCA ultrasound video recordings were captured with screen recording software (Camtasia, TechSmith, East Lansing, MI), and subsequently analyzed for blood velocity and vessel diameter via specialized wall-tracking software (Cardiovascular Suite, Quipu, Pisa, Italy). Cross-sectional area of the CCA was calculated as π(diameter/2)2. Mean blood velocity was calculated as (peak blood velocity)/2. CCA blood flow was then calculated as (1-minute-averaged mean blood velocity) × (vessel cross-sectional area). CCA conductance was calculated as CCA blood flow divided by MAP. Mean MCAv was calculated from the cerebral blood velocity waveform. MCAv conductance index was calculated as mean MCAv divided by MAP. MCAv and CCA blood flow measurements are reported from the side ipsilateral to the LMV placement.

Power spectral density – a measurement of the amplitude of hemodynamic oscillations analyzed as a function of frequency – was calculated for R-R intervals (RRI), SAP, MAP, and MCAv via fast Fourier transform analysis as previously described from our laboratory35. Data were made equidistant by interpolating linearly and resampling at 5 Hz. Data were then passed through a low-pass filter with a cutoff frequency of 0.5 Hz. Data sets underwent fast Fourier transform with a Hanning window using the Welch method to compute power spectral density within the very low frequency (VLF, 0.04–0.07 Hz), low frequency (LF, 0.07–0.15 Hz), and high frequency (HF, 0.15–0.40 Hz) bands. RRI HF power was used as an index of cardiac vagal activity36. The coherence between SAP and RRI, and between MAP and MCAv were calculated by dividing the squared cross-spectral densities of the two signals by the product of the individual autospectra. Transfer function phase and gain between SAP and RRI, and between MAP and MCAv were calculated within the VLF and LF frequency bands, and only if the corresponding coherence was ≥ 0.5. Cardiac baroreflex sensitivity was assessed via LF SAP-RRI transfer function analysis37 and the SAP-RRI sequence method38. For the transfer function analysis, an increase in baroreflex sensitivity is represented by a decrease in SAP-RRI phase or an increase in SAP-RRI gain, and vice versa. For the sequence method, BRS up-up refers to increases in RRIs (i.e., decreases in heart rate) in response to an increase in SAP, while BRS down-down refers to decreases in RRIs (i.e., increases in heart rate) in response to a decrease in SAP; an increase in the gain of these ratios indicates greater cardiac baroreflex sensitivity. The LF and VLF phase and gain between MAP and MCAv were used as indices of dynamic cerebral autoregulation39. An impairment in dynamic cerebral autoregulation can be interpreted from either higher MAP-MCAv coherence, lower phase, or higher gain, and vice versa.

Time domain and frequency domain data were averaged over the final 4 min of baseline, the LMV period, and recovery, except for the CCA measurements, which were averaged over the final 1 min of baseline and the LMV period (data were not collected during recovery) based on the minimum amount of data available for all participants. Normality of data distribution was assessed using the Shapiro-Wilk test. Normally distributed data were analyzed over the 3 time periods (baseline, LMV period, and recovery) via one-way repeated measures ANOVAs, followed by Tukey’s post hoc tests. Non-normally distributed data were analyzed via Friedman’s test, followed by Dunn’s multiple comparisons test. Normally distributed CCA data were analyzed with paired t-tests (baseline, LMV period), while non-normally distributed data were analyzed via Wilcoxon tests. Statistical analyses were performed via GraphPad Prism 10 (GraphPad Software, San Diego, CA, USA). All data are presented as mean ± SD, and exact P-values are presented for all comparisons, allowing the reader to make their own judgments and interpretation of the results, rather than the dichotomous use of the term “statistically significant”40,41. Any statistical comparison with a P-value ≤0.08 has been highlighted, as these responses may be physiologically meaningful. As a further assessment of the magnitude of response, Cohen’s d effect size statistics are also presented for select comparisons.

RESULTS

Participants

Eleven participants were recruited for this study, but one female participant withdrew after completing the familiarization session due to scheduling restraints. As a result, ten participants (five females and five males) completed the entire protocol and were included in the final analysis (table 1). In order to avoid any potential order effect, LMV was applied to the right side first in 5 participants, and the left side first in 5 participants, based on a randomized approach.

Table 1.

Participant Demographics

Characteristic N = 10
Sex
 Female 5 (50%)
 Male 5 (50%)
Ethnicity/Race
 Hispanic Asian 0 (0%)
 Hispanic White 1 (10%)
 Non-Hispanic Asian 3 (30%)
 Non-Hispanic White 6 (60%)
Age (years) 25.2 ± 2.2
Height (cm) 169.4 ± 8.6
Weight (kg) 66.7 ± 13.7
BMI (kg/m2) 23.0 ± 3.1
BSA (m2) 1.8 ± 0.2

Data are presented as mean ± SD. BMI, body mass index; BSA, body surface area.

Participants did not report any adverse events or symptoms following the LMV, and all participants were able to complete the entire protocol; no participant expressed pain or discomfort due to the LMV.

Cardiorespiratory Responses

There was no effect of LMV on either the left or ride side of the neck for heart rate, MAP, stroke volume, or systemic vascular conductance (tables 2 and 3, and figure 2 for MAP). Cardiac output did not change during LMV on the right side, but increased slightly (~0.1 L/min) during recovery (P = 0.03; Cohen’s d = 0.09; table 2). Cardiac output increased slightly during LMV on the left side (~0.1 L/min; P = 0.05; Cohen’s d = 0.10; table 3), but returned to baseline values during recovery. There was no effect of LMV on RRI HF power, an index of cardiac vagal activity (P ≥ 0.60). The only effect of LMV on cardiac baroreflex sensitivity was an increase in SAP-RRI LF phase during recovery when LMV was applied to the right side (P = 0.005; table 2), an indication of reduced cardiac baroreflex sensitivity. No other changes in cardiac baroreflex sensitivity occurred with LMV.

Table 2.

Physiological Responses During RIGHT Side Local Muscle Vibration (LMV)

Parameter Baseline LMV Recovery Main Effect
P-value
Cardiovascular
 Heart rate (beats/min) 76.5 ± 12.8 77.2 ± 12.4 77.9 ± 11.2 0.22
 R-R intervals (ms) 810 ± 133 801 ± 126 793 ± 115 0.30
 MAP (mmHg) 96.9 ± 4.9 97.8 ± 5.7 98.2 ± 4.6 0.25
 Stroke volume (ml) 73.9 ± 16.6 74.2 ± 16.9 73.6 ± 15.5 0.60
 Cardiac output (L/min) 5.6 ± 1.1 5.6 ± 1.1 5.7 ± 1.1* 0.08
 Systemic vascular conductance (ml/min/mmHg) 57.7 ± 12.7 57.9 ± 12.5 57.8 ± 11.3 0.93
 Mean BRS up-up (ms/mmHg) 13.2 ± 5.8 12.6 ± 5.6 13.5 ± 5.7 0.63
 Mean BRS down-down (ms/mmHg) 14.0 ± 6.7 13.1 ± 5.4 13.6 ± 4.8 0.61
Cerebrovascular
 Middle Cerebral Artery
  Mean MCAv (cm/s) 61.4 ± 10.5 62.0 ± 10.7 59.3 ± 9.7 0.15
  Conductance index (cm/s/mmHg) 0.64 ± 0.12 0.64 ± 0.11 0.60 ± 0.10 0.08
 Common Carotid Artery
  Vessel diameter (mm) 6.2 ± 0.6 6.3 ± 0.7* . 0.03
  Blood velocity (cm/s) 19.0 ± 6.9 17.8 ± 4.8 . 0.19
  Blood flow (ml/min) 330.7 ± 68.5 324.7 ± 57.6 . 0.59
  Conductance (ml/min/mmHg) 3.4 ± 0.6 3.3 ± 0.6 . 0.58
 Cerebral Tissue Oxygenation
  ScO2 (%) 73.7 ± 6.7 74.7 ± 6.9 74.9 ± 7.4* 0.007
  Total hemoglobin (μM) 46.7 ± 12.7 47.1 ± 12.9 47.7 ± 13.4* 0.05
  Oxyhemoglobin (μM) 33.9 ± 7.9 34.7 ± 8.3 35.2 ± 8.2* 0.01
  Deoxyhemoglobin (μM) 12.7 ± 6.1 12.3 ± 6.0* 12.5 ± 6.6 0.25
Respiratory
 etCO2 (mmHg) 35.3 ± 3.8 35.4 ± 3.4 34.6 ± 3.7*^ 0.02
 Respiratory rate (breaths/min) 14.2 ± 3.9 14.1 ± 3.7 12.0 ± 3.1*^ 0.0005
Frequency Domain
 R-R interval PSD (HF) (ms2) 1172 ± 1364 1689 ± 2198 992 ± 892 0.71
 SAP-RRI (LF)
  Coherence 0.75 ± 0.14 0.81 ± 0.11 0.75 ± 0.10 0.11
  Phase (degrees) −48.5 ± 12.9 −48.5 ± 12.6 −57.3 ± 16.8^ 0.003
  Gain (ms/mmHg) 11.2 ± 3.6 12.4 ± 5.1 12.7 ± 3.8 0.27
 MAP-MCAv (VLF)
  MAP PSD (mmHg2) 2.7 ± 0.9 3.8 ± 3.8 4.4 ± 2.9 0.31
  MCAv PSD (cm/s)2 1.5 ± 1.0 2.1 ± 2.0 2.7 ± 1.8 0.08
  Coherence 0.58 ± 0.15 0.54 ± 0.27 0.57 ± 0.19 0.90
  Phase (degrees) 63.4 ± 15.3 46.5 ± 18.5 58.0 ± 17.8 .
  Gain (cm/s/mmHg) 0.66 ± 0.27 0.62 ± 0.19 0.67 ± 0.10 .
 MAP-MCAv (LF)
  MAP PSD (mmHg2) 5.2 ± 3.7 5.3 ± 3.3 8.3 ± 6.7*^ 0.007
  MCAv PSD (cm/s)2 3.74 ± 3.9 3.9 ± 3.2 6.2 ± 7.5 0.19
  Coherence 0.80 ± 0.16 0.85 ± 0.07 0.74 ± 0.18 0.20
  Phase (degrees) 37.8 ± 6.9 36.2 ± 8.7 38.3 ± 13.6 0.74
  Gain (cm/s/mmHg) 0.80 ± 0.15 0.81 ± 0.11 0.75 ± 0.15 0.27
*

denotes P ≤ 0.08 vs. Baseline

^

denotes P ≤ 0.06 vs. LMV. BRS, baroreflex sensitivity; MCAv, middle cerebral artery blood velocity; ScO2, cerebral oxygen tissue saturation; etCO2, end-tidal carbon dioxide; HF, high frequency; LF, low frequency; VLF, very low frequency; PSD, power spectral density. Data are presented as mean ± SD.

Italicized P-values represent non-normal distribution of data, with subsequent application of non-parametric statistical tests. Statistical analyses were not performed for MAP-MCAv VLF phase and gain due to low coherence (i.e., < 0.5) in 7/10 participants for at least one time point.

Table 3.

Physiological Responses During LEFT Side Local Muscle Vibration (LMV)

Parameter Baseline LMV Recovery Main effect P-value
Cardiovascular
 Heart rate (beats/min) 74.9 ± 10.7 75.9 ± 10.9 76.9 ± 11.0 0.18
 R-R intervals (ms) 822 ± 119 810 ± 116 802 ± 117 0.24
 MAP (mmHg) 96.0 ± 7.8 97.0 ± 7.7 97.9 ± 7.5 0.23
 Stroke volume (ml) 73.8 ± 14.9 74.3 ± 15.0 72.8 ± 15.0 0.19
 Cardiac output (L/min) 5.5 ± 1.0 5.6 ± 1.0* 5.5 ± 1.1 0.14
 Systemic vascular conductance (ml/min/mmHg) 56.9 ± 9.4 57.5 ± 9.8 56.6 ± 10.7 0.58
 Mean BRS up-up (ms/mmHg) 13.4 ± 6.2 12.9 ± 5.4 14.7 ± 6.8 0.40
 Mean BRS down-down (ms/mmHg) 14.7 ± 6.4 15.3 ± 8.1 12.5 ± 6.0 0.19
Cerebrovascular
 Middle Cerebral Artery
  Mean MCAv (cm/s) 59.9 ± 10.2 60.6 ± 10.8 58.4 ± 10.2 0.20
  Conductance index (cm/s/mmHg) 0.62 ± 0.10 0.63 ± 0.10 0.60 ± 0.11*^ 0.02
 Common Carotid Artery
  Vessel diameter (mm) 6.4 ± 0.5 6.5 ± 0.5* . 0.03
  Blood velocity (cm/s) 18.6 ± 1.8 17.3 ± 2.8 . 0.11
  Blood flow (ml/min) 358.1 ± 67.5 344.2 ± 78.3 . 0.30
  Conductance (ml/min/mmHg) 3.8 ± 1.0 3.6 ± 1.1 . 0.10
 Cerebral Tissue Oxygenation
  ScO2 (%) 72.6 ± 8.5 72.9 ± 8.8 72.8 ± 9.2 0.53
  Total hemoglobin (μM) 46.0 ± 11.3 46.1 ± 11.2 46.5 ± 11.4 0.26
  Oxyhemoglobin (μM) 33.6 ± 9.4 33.8 ± 9.4 34.0 ± 9.4 0.47
  Deoxyhemoglobin (μM) 12.4 ± 4.8 12.3 ± 4.8 12.5 ± 5.3 0.35
Respiratory
 etCO2 (mmHg) 34.3 ± 4.0 35.2 ± 3.6 33.5 ± 3.9^ 0.05
 Respiratory rate (breaths/min) 13.7 ± 4.3 14.7 ± 3.9 13.1 ± 3.5^ 0.05
Frequency domain
 R-R interval PSD (HF) (ms2) 1277 ± 1710 1411 ± 1804 814 ± 751 0.60
 SAP-RRI PSD (LF)
  Coherence 0.75 ± 0.13 0.79 ± 0.16 0.75 ± 0.18 0.45
  Phase (degrees) −51.8 ± 11.5 −48.0 ± 13.1 −50.0 ± 11.7 0.79
  Gain (ms/mmHg) 13.6 ± 6.2 13.3 ± 5.2 13.8 ± 5.4 0.84
 MAP-MCAv PSD (VLF)
  MAP PSD (mmHg2) 3.9 ± 3.5 4.1 ± 3.5 4.8 ± 3.7 0.32
  MCAv PSD (cm/s)2 2.1 ± 1.6 2.0 ± 1.5 2.4 ± 2.0 0.97
  Coherence 0.61 ± 0.15 0.59 ± 0.20 0.60 ± 0.19 0.97
  Phase (degrees) 64.9 ± 24.3 52.6 ± 15.1 34.4 ± 18.6 0.13
  Gain (cm/s/mmHg) 0.47 ± 0.06 0.56 ± 0.06 0.55 ± 0.20 0.36
 MAP-MCAv PSD (LF)
  MAP PSD (mmHg2) 4.2 ± 2.6 4.9 ± 2.2 8.0 ± 5.6* 0.02
  MCAv PSD (cm/s)2 2.5 ± 2.6 2.4 ± 1.7 4.0 ± 2.8^ 0.03
  Coherence 0.78 ± 0.09 0.81 ± 0.11 0.80 ± 0.11 0.97
  Phase (degrees) 42.5 ± 14.7 40.8 ± 11.8 45.0 ± 29.8 0.83
  Gain (cm/s/mmHg) 0.71 ± 0.20 0.68 ± 0.15 0.69 ± 0.13 0.70
*

denotes P ≤ 0.05 vs. Baseline.

^

denotes P ≤ 0.08 vs. LMV. BRS, baroreflex sensitivity; MCAv, middle cerebral artery blood velocity; ScO2, cerebral oxygen tissue saturation; etCO2, end-tidal carbon dioxide; HF, high frequency; LF, low frequency; VLF, very low frequency; PSD, power spectral density. Data are presented as mean ± SD.

Italicized P-values represent non-normal distribution of data, with subsequent application of non-parametric statistical tests.

Figure 2.

Figure 2

Mean arterial pressure (MAP) at baseline (BL), during local muscle vibration (LMV), and during recovery (REC) on the right side (A) and left side of the neck (B). All individual participant data and mean data are presented. Comparisons were made via one-way repeated measures ANOVAs followed by Tukey’s post hoc tests.

There was an overall decrease in respiratory rate when LMV was applied to the right (main effect P = 0.0005) and left (main effect P = 0.05) sides, and pairwise differences were detected during recovery on the left side compared to the LMV period (P = 0.08); Cohen’s d = −0.43; table 3) and on the right side when compared with both the baseline (P = 0.008; Cohen’s d = −0.62; table 2) and LMV periods (P = 0.002; Cohen’s d = −0.62; table 2). End-tidal CO2 also decreased in recovery compared to both baseline (P = 0.06; Cohen’s d = −0.19; table 2) and LMV periods (P = 0.06; Cohen’s d = −0.23; table 2) on the right side, and decreased during recovery compared to LMV on the left side (P = 0.07; Cohen’s d = −0.45; table 3).

Cerebrovascular Responses

CCA diameter increased slightly when LMV was applied to both the right (P = 0.03; Cohen’s d = 0.15; table 2) and left (P = 0.03; Cohen’s d = 0.20; table 3) sides of the neck. However, there were no differences in CCA blood velocity, blood flow, or vascular conductance with LMV on either side of the neck (figure 3). There were also no differences in mean MCAv with LMV. MCAv conductance index did not change when LMV was applied to the right side of the neck, but decreased during recovery when applied to the left side of the neck compared to baseline (P = 0.04; Cohen’s d = −0.19; table 3) and compared to LMV (P = 0.08; Cohen’s d = −0.19; table 3).

Figure 3.

Figure 3

Common carotid artery measurements at baseline (BL) and during local muscle vibration (LMV) on the right side (A) and left side of the neck (B). All individual participant data and mean data are presented. Comparisons were made via paired t-tests or Wilcoxon tests.

The responses of cerebral tissue oxygenation to LMV were mixed and inconsistent between each side of the neck. On the right side, ScO2 (P = 0.01; Cohen’s d = 0.17; table 2) and oxyhemoglobin concentration (P = 0.004; Cohen’s d = 0.16; table 2) increased during recovery compared to baseline, and deoxyhemoglobin decreased during LMV compared to baseline (P = 0.03; Cohen’s d = −0.07; table 2). There was also a main effect for total hemoglobin concentration when LMV was applied to the right side (P = 0.05; table 2), with an increase during recovery compared to baseline (P = 0.08; Cohen’s d = 0.08; table 2). On the left side, there were no differences in any of the NIRS-derived parameters with LMV or during recovery (all main effect P-values ≥ 0.26).

Dynamic cerebral autoregulation was assessed via transfer function analysis between MAP and MCAv in the VLF and LF ranges. MAP and MCAv VLF power did not change when LMV was applied to either side of the neck. There were also no differences in VLF MAP-MCAv coherence when LMV was applied to either side of the neck. Statistical analyses were not performed for VLF MAP-MCAv phase or gain when LMV was applied to the right side due low coherence (i.e., < 0.5) in 7 out of 10 participants for at least one time point. There were no differences in VLF MAP-MCAv phase and gain when LMV was applied to the left side (n = 8).

MAP LF power increased during recovery compared with baseline (P = 0.02; table 2) and LMV (P = 0.02; table 2) when LMV was applied to the right side, and increased during recovery compared with baseline when LMV was applied to the left side (P = 0.02; table 3). There was also an increase in MCAv LF power during recovery compared to LMV when applied to the left side (P = 0.06; table 3), but no differences in MCAv LF power when LMV was applied to the right side. There were no differences in MAP-MCAv LF coherence, phase, or gain when LMV was applied to either side of the neck.

DISCUSSION

In this study, we sought to assess the safety of LMV on the smaller muscles of the anterior neck in young and healthy participants, with a particular focus on acute cardiovascular and cerebral blood flow responses. Our key findings are that: 1) there were minimal effects on key cardiovascular parameters, including heart rate and arterial pressure, and; 2) there was a small increase in CCA vessel diameter, but no effect on CCA blood flow.

High frequency LMV has shown promise as a rehabilitative tool to restore neuromotor function2–10, but the safety of this technique when applied to the anterior neck must be demonstrated before its rehabilitative potential can be evaluated. To our knowledge, this is the first study to evaluate the acute cardiovascular effects of LMV on the small musculature of the anterior neck. LMV in this location led to small elevations in cardiac output and cerebral tissue oxygenation (via increased oxyhemoglobin), and small changes in end-tidal CO2 and respiratory rate, albeit all during the recovery phase; these small physiological effects are also supported by small effect size statistics. LMV had no impact on heart rate or arterial pressure. In the frequency domain, we observed a small increase in SAP-RRI phase in the low frequency range, indicating reduced baroreflex sensitivity. However, this response only occurred during recovery, and only when LMV was applied to the right side, so the physiological relevance is limited.

Prior studies have demonstrated that high frequency vibration can increase blood flow. For example, elevations in skin blood flow and/or skin vasodilation have been shown when high frequency vibration was applied to various locations in the body, including the forearm18, the calf muscles26, and the face27, while popliteal artery blood flow increased in response to high frequency vibration on the calf28. Accordingly, we hypothesized that LMV applied to the anterior neck near the carotid arteries would increase CCA blood flow.

While there was no change in CCA blood flow with 80 Hz LMV, the observed dilation of the CCA aligns with these aforementioned studies. There are two possible explanations for this vasodilatory effect. First, the majority of blood flowing through the CCA supplies cerebral tissue (via the internal carotid artery), while only a small percentage contributes to extracranial blood flow (via the external carotid artery)42. Cerebral blood flow is typically well-regulated to meet metabolic demand under resting conditions, so it is not surprising that CCA blood flow was unchanged with LMV even with vasodilation. Indeed, CCA blood velocity was numerically lower during LMV for both sides of the neck (P-values of 0.11 and 0.19), and perfusion pressure (i.e., MAP) was stable, leading to no change in CCA blood flow despite the vasodilation. Second, we tested young and healthy participants, without any impairments in CCA structure or blood flow, so there was no deficit to be improved upon with LMV. While LMV-induced CCA vasodilation was small, it is possible that this vasodilatory effect could be magnified in an older population with vascular impairment and/or reduced basal cerebral blood flow, and could subsequently lead to increases in CCA blood flow; this is an important next step for application of LMV to older individuals.

The most likely explanation for LMV-induced vasodilation and increases in blood flow is vibration-induced shear stress, leading to the local release of nitric oxide (NO) from endothelial cells. Pulsatile blood flow is known to increase endothelial NO production compared with continuous blood flow43–45. Mechanical stress on the vascular wall due to increases in shear stress46 and exercise are known to increase NO production or NO synthase expression; it has been suggested that mechanical stress due to vibration may similarly cause NO-induced vasodilation48. For instance, whole body periodic acceleration (pGz) at low frequencies (3–6 Hz) produces pulsatile perfusion, and subsequently increases NO production in animal studies49–51. Local vibration devices have also been shown to elicit similar increases in NO production. In an in vivo mouse skin microcirculation model, Ichioka et al. demonstrated that 47 Hz vibration increased blood flow, which was subsequently abolished by intraperitoneal injection of the NO synthase inhibitor L-NAME, implicating the involvement of NO in vibration-induced vasodilation and hyperemia52. Moreover, vibration wound therapy in humans increased NO concentrations, as mentioned above30. Therefore, it is likely that LMV-induced shear stress causes increased endothelial NO production, ultimately leading to the observed vasodilation in our study. However, measurements of circulating NO are needed to confirm this potential explanation.

Increased blood flow with LMV could be a mechanism to improve swallowing function in the acute post-stroke setting. Several studies using local vibrations at frequencies in the 80 Hz range have demonstrated neuromuscular re-education in individuals with impaired vasculature, corresponding with increased blood velocity in their lower extremities13–25. Our study is the first to apply LMV to the anterior neck, and demonstrated the safety of this technique in regards to cardiovascular and cerebral blood flow responses in young and healthy participants. This is the first step to eventually testing the efficacy of LMV in rehabilitating muscle function for stroke patients.

Methodological Considerations

There are some methodological considerations that should be discussed. As mentioned above, this study was performed in young and healthy individuals, without impaired vascular function or blood flow. While this is an essential first step in demonstrating the safety of LMV on the anterior neck, further studies are needed in older healthy participants prior to application in a post-stroke population. A vascular health exam would also be needed to exclude participants with underlying vascular pathology that could be a contraindication with the LMV approach (e.g., atherosclerosis). Furthermore, only an acute 5-minute stimulus with a single LMV frequency (80 Hz) was used in this study, so the impact of different frequencies, longer duration and/or repeated stimulation over time is unknown and requires further exploration in future studies. Additionally, participants were in the upright seated position, and assessment of cerebral blood velocity and cerebral tissue oxygenation required application of multiple pieces of equipment to the head (transcranial Doppler ultrasound and NIRS). In some participants, this arrangement of equipment became uncomfortable over time. However, we did not observe any consistent changes in key pain-related cardiovascular parameters, such as heart rate, arterial pressure, or respiratory rate. Another methodological consideration is the inherent variability in positioning and pressure of the hand-held LMV device. A wearable device holder could be used in future studies to ensure a consistent position and pressure application. Finally, we noticed that the vibration of the LMV device could be seen in our ultrasound recordings of the CCA (Figure 4). This did not affect our analysis or results, as we used measures of time-averaged peak blood velocity, which was then converted to mean blood velocity, and there was no retrograde flow (as is usually the case with CCA velocity in healthy blood vessels). However, those wishing to further investigate the effects of LMV on blood flow responses should be aware that it may cause some interference in the ultrasound recording, depending on the analysis software used, particularly if it utilizes measures of intensity-weighted mean blood velocity, or retrograde flow exists (such as in the periphery).

Figure 4.

Figure 4

Representative example of common carotid artery ultrasound image captured via duplex Doppler ultrasound. during baseline (top) and during LMV (bottom). Of note is the local muscle vibration effect appearing on the velocity tracing on the x-axis during LMV (indicated by the red arrow).

In conclusion, our study provides evidence that anterior neck LMV at 80 Hz can be safely used without resulting in major changes to key cardiovascular parameters in young and healthy participants. Although there was a small increase in CCA diameter, there was no subsequent change in blood flow. These findings are an important starting point for future studies investigating the potential rehabilitative effects of LMV to improve symptoms in post-stroke patients.

ACKNOWLEDGEMENTS

We thank the participants of this study for their time and willingness to participate. We also thank Dr. Albert H. Olivencia-Yurvati for his assistance with participant medical reviews. Funding for this study was provided via a contract with Sola Gratia, LLC. VQD was funded by a National Institutes of Health (NIH)-supported Neurobiology of Aging Training Grant (T32 AG020494, Principal Investigator: N. Sumien). KAD was funded by an American Heart Association Predoctoral Fellowship (23PRE1018469).

DISCLOSURES

Dr. Malinda Hansen is the sole founder, CEO, and President of Sola Gratia, LLC, a for-profit company that created the LMV device used in this study. Sola Gratia, LLC holds all patent rights and intellectual property of this device. If this device is approved by the FDA, Dr. Hansen will directly benefit from the sale of this product.

Footnotes

No conflicts of interest, financial or otherwise, are declared by the other authors.

DATA AVAILABILITY

Data will be made available upon reasonable request.

REFERENCES

  • 1.Charcot JM. Vibratory therapeutics.--The application of rapid and continuous vibrations to the treatment of certain diseases of the nervous system. 1892. J Nerv Ment Dis Nov 2011;199(11):821–7. doi: 10.1097/NMD.0b013e31823899bc [DOI] [PubMed] [Google Scholar]
  • 2.Fateh HR, Nakhostin Ansari N, Nakhostin-Ansari A, et al. The effects of local calf vibration on balance, blood flow, and nerve conductivity in patients with diabetic peripheral neuropathy: a pilot study. Physiother Theory Pract Jul 2024;40(7):1397–1403. doi: 10.1080/09593985.2023.2173992 [DOI] [PubMed] [Google Scholar]
  • 3.Masud AA, Shen CL, Luk HY, Chyu MC. Impact of Local Vibration Training on Neuromuscular Activity, Muscle Cell, and Muscle Strength: A Review. Crit Rev Biomed Eng 2022;50(1):1–17. doi: 10.1615/CritRevBiomedEng.2022041625 [DOI] [PubMed] [Google Scholar]
  • 4.Coulondre C, Souron R, Rambaud A, et al. Local vibration training improves the recovery of quadriceps strength in early rehabilitation after anterior cruciate ligament reconstruction: A feasibility randomised controlled trial. Ann Phys Rehabil Med Jun 2022;65(4):101441. doi: 10.1016/j.rehab.2020.08.005 [DOI] [PubMed] [Google Scholar]
  • 5.Blackburn T, Padua DA, Pietrosimone B, et al. Vibration improves gait biomechanics linked to posttraumatic knee osteoarthritis following anterior cruciate ligament injury. J Orthop Res May 2021;39(5):1113–1122. doi: 10.1002/jor.24821 [DOI] [PubMed] [Google Scholar]
  • 6.Maghbouli N, Khodadost M, Pourhassan S. The effectiveness of vibration therapy for muscle peak torque and postural control in individuals with anterior cruciate ligament reconstruction: a systematic review and meta-analysis of clinical trials. J Orthop Traumatol Jul 14 2021;22(1):28. doi: 10.1186/s10195-021-00589-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Avvantaggiato C, Casale R, Cinone N, et al. Localized muscle vibration in the treatment of motor impairment and spasticity in post-stroke patients: a systematic review. Eur J Phys Rehabil Med Feb 2021;57(1):44–60. doi: 10.23736/S1973-9087.20.06390-X [DOI] [PubMed] [Google Scholar]
  • 8.Paolucci T, Pezzi L, La Verde R, Latessa PM, Bellomo RG, Saggini R. The Focal Mechanical Vibration for Balance Improvement in Elderly - A Systematic Review. Clin Interv Aging. 2021;16:2009–2021. doi: 10.2147/CIA.S328638 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Souron R, Baudry S, Millet GY, Lapole T. Vibration-induced depression in spinal loop excitability revisited. J Physiol Nov 2019;597(21):5179–5193. doi: 10.1113/jp278469 [DOI] [PubMed] [Google Scholar]
  • 10.Souron R, Besson T, Millet GY, Lapole T. Acute and chronic neuromuscular adaptations to local vibration training. Eur J Appl Physiol Oct 2017;117(10):1939–1964. doi: 10.1007/s00421-017-3688-8 [DOI] [PubMed] [Google Scholar]
  • 11.Cirillo C, Brihmat N, Castel-Lacanal E, et al. Post-stroke remodeling processes in animal models and humans. J Cereb Blood Flow Metab Jan 2020;40(1):3–22. doi: 10.1177/0271678X19882788 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Jamal K, Leplaideur S, Leblanche F, Moulinet Raillon A, Honore T, Bonan I. The effects of neck muscle vibration on postural orientation and spatial perception: A systematic review. Neurophysiol Clin Sep 2020;50(4):227–267. doi: 10.1016/j.neucli.2019.10.003 [DOI] [PubMed] [Google Scholar]
  • 13.Peer KS, Barkley JE, Knapp DM. The acute effects of local vibration therapy on ankle sprain and hamstring strain injuries. Phys Sportsmed Dec 2009;37(4):31–8. doi: 10.3810/psm.2009.12.1739 [DOI] [PubMed] [Google Scholar]
  • 14.Zinke F, Gebel A, Granacher U, Prieske O. Acute Effects of Short-Term Local Tendon Vibration on Plantar Flexor Torque, Muscle Contractile Properties, Neuromuscular and Brain Activity in Young Athletes. J Sports Sci Med Jun 2019;18(2):327–336. [PMC free article] [PubMed] [Google Scholar]
  • 15.Roll JP, Vedel JP, Ribot E. Alteration of proprioceptive messages induced by tendon vibration in man: a microneurographic study. Exp Brain Res 1989;76(1):213–22. doi: 10.1007/BF00253639 [DOI] [PubMed] [Google Scholar]
  • 16.Farabet A, Souron R, Millet GY, Lapole T. Changes in tibialis anterior corticospinal properties after acute prolonged muscle vibration. Eur J Appl Physiol Jun 2016;116(6):1197–205. doi: 10.1007/s00421-016-3378-y [DOI] [PubMed] [Google Scholar]
  • 17.Couto BP, Silva HR, Barbosa MP, Szmuchrowski LA. Chronic effects of different frequencies of local vibrations. Int J Sports Med Feb 2012;33(2):123–9. doi: 10.1055/s-0031-1286294 [DOI] [PubMed] [Google Scholar]
  • 18.Maloney-Hinds C, Petrofsky JS, Zimmerman G. The effect of 30 Hz vs. 50 Hz passive vibration and duration of vibration on skin blood flow in the arm. Med Sci Monit Mar 2008;14(3):CR112–6. [PubMed] [Google Scholar]
  • 19.Alghadir AH, Anwer S, Zafar H, Iqbal ZA. Effect of localised vibration on muscle strength in healthy adults: a systematic review. Physiotherapy. Mar 2018;104(1):18–24. doi: 10.1016/j.physio.2017.06.006 [DOI] [PubMed] [Google Scholar]
  • 20.Fuller JT, Thomson RL, Howe PR, Buckley JD. Effect of vibration on muscle perfusion: a systematic review. Clin Physiol Funct Imaging. Jan 2013;33(1):1–10. doi: 10.1111/j.1475-097X.2012.01161.x [DOI] [PubMed] [Google Scholar]
  • 21.Alashram AR, Padua E, Romagnoli C, Annino G. Effectiveness of focal muscle vibration on hemiplegic upper extremity spasticity in individuals with stroke: A systematic review. NeuroRehabilitation. Dec 18 2019;45(4):471–481. doi: 10.3233/NRE-192863 [DOI] [PubMed] [Google Scholar]
  • 22.Thompson C, Belanger M, Fung J. Effects of bilateral Achilles tendon vibration on postural orientation and balance during standing. Clin Neurophysiol Nov 2007;118(11):2456–67. doi: 10.1016/j.clinph.2007.08.013 [DOI] [PubMed] [Google Scholar]
  • 23.Mohd Mukhtar A AA, Mohd F. Effects of different vibration therapy protocols on neuromuscular performance. Muscles, Ligaments and Tendons Journal. 2021;11(1):161–177. doi: 10.32098/mltj.01.2021.17 [DOI] [Google Scholar]
  • 24.Germann D, El Bouse A, Shnier J, Abdelkader N, Kazemi M. Effects of local vibration therapy on various performance parameters: a narrative literature review. J Can Chiropr Assoc Dec 2018;62(3):170–181. [PMC free article] [PubMed] [Google Scholar]
  • 25.Wang HCR, Rippetoe J, Ghazi M. Focal Muscle Vibration for Stroke Rehabilitation: A Review of Vibration Parameters and Protocols. Applied Sciences. 2020;10(22)doi: 10.3390/app10228270 [DOI] [Google Scholar]
  • 26.Lohman EB 3rd, Bains GS, Lohman T, DeLeon M, Petrofsky JS. A comparison of the effect of a variety of thermal and vibratory modalities on skin temperature and blood flow in healthy volunteers. Med Sci Monit Sep 2011;17(9):MT72–81. doi: 10.12659/msm.881921 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Skoglund CR. Vasodilatation in human skin induced by low-amplitude high-frequency vibration. Clin Physiol Aug 1989;9(4):361–72. doi: 10.1111/j.1475-097x.1989.tb00990.x [DOI] [PubMed] [Google Scholar]
  • 28.Needs D, Blotter J, Cowan M, Fellingham G, Johnson AW, Feland JB. Effect of Localized Vibration Massage on Popliteal Blood Flow. J Clin Med Mar 4 2023;12(5)doi: 10.3390/jcm12052047 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Arashi M, Sugama J, Sanada H, et al. Vibration therapy accelerates healing of Stage I pressure ulcers in older adult patients. Adv Skin Wound Care. Jul 2010;23(7):321–7. doi: 10.1097/01.ASW.0000383752.39220.fb [DOI] [PubMed] [Google Scholar]
  • 30.Syabariyah S, Nurachmah E, Widjojo BD, et al. The Effect of Vibration on the Acceleration of Wound Healing of Diabetic Neuropathic Foot Ulcer: A Prospective Experimental Study on Human Patients. Healthcare (Basel). Jan 9 2023;11(2)doi: 10.3390/healthcare11020191 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Liao F, Zhang K, Zhou L, Chen Y, Elliott J, Jan YK. Effect of Different Local Vibration Frequencies on the Multiscale Regularity of Plantar Skin Blood Flow. Entropy (Basel). Nov 13 2020;22(11)doi: 10.3390/e22111288 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Ren W, Pu F, Luan H, et al. Effects of Local Vibration With Different Intermittent Durations on Skin Blood Flow Responses in Diabetic People. Front Bioeng Biotechnol 2019;7:310. doi: 10.3389/fbioe.2019.00310 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Maloney-Hinds C, Petrofsky JS, Zimmerman G, Hessinger DA. The role of nitric oxide in skin blood flow increases due to vibration in healthy adults and adults with type 2 diabetes. Diabetes Technol Ther Jan 2009;11(1):39–43. doi: 10.1089/dia.2008.0011 [DOI] [PubMed] [Google Scholar]
  • 34.Espeit L, Lapole T. Effects of graduated compression stockings, local vibration and their combination on popliteal venous blood velocity. Phlebology. Aug 2020;35(7):505–512. doi: 10.1177/0268355520902000 [DOI] [PubMed] [Google Scholar]
  • 35.Rickards CA, Sprick JD, Colby HB, Kay VL, Tzeng YC. Coupling between arterial pressure, cerebral blood velocity, and cerebral tissue oxygenation with spontaneous and forced oscillations. Physiol Meas Apr 2015;36(4):785–801. doi: 10.1088/0967-3334/36/4/785 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Akselrod S, Gordon D, Ubel FA, Shannon DC, Berger AC, Cohen RJ. Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. Science. Jul 10 1981;213(4504):220–2. doi: 10.1126/science.6166045 [DOI] [PubMed] [Google Scholar]
  • 37.Cooke WH, Convertino VA. Heart rate variability and spontaneous baroreflex sequences: implications for autonomic monitoring during hemorrhage. J Trauma Apr 2005;58(4):798–805. doi: 10.1097/01.ta.0000151345.16338.fd [DOI] [PubMed] [Google Scholar]
  • 38.Rothlisberger BW, Badra LJ, Hoag JB, et al. Spontaneous ‘baroreflex sequences’ occur as deterministic functions of breathing phase. Clin Physiol Funct Imaging. Nov 2003;23(6):307–13. doi: 10.1046/j.1475-0961.2003.00489.x [DOI] [PubMed] [Google Scholar]
  • 39.Claassen JA, Meel-van den Abeelen AS, Simpson DM, Panerai RB, international Cerebral Autoregulation Research N. Transfer function analysis of dynamic cerebral autoregulation: A white paper from the International Cerebral Autoregulation Research Network. J Cereb Blood Flow Metab Apr 2016;36(4):665–80. doi: 10.1177/0271678X15626425 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Curran-Everett D Evolution in statistics: P values, statistical significance, kayaks, and walking trees. Adv Physiol Educ Jun 1 2020;44(2):221–224. doi: 10.1152/advan.00054.2020 [DOI] [PubMed] [Google Scholar]
  • 41.Curran-Everett D, Benos DJ. Guidelines for reporting statistics in journals published by the American Physiological Society. Am J Physiol Regul Integr Comp Physiol Aug 2004;287(2):R247–9. doi: 10.1152/ajpregu.00346.2004 [DOI] [PubMed] [Google Scholar]
  • 42.Sato K, Ogoh S, Hirasawa A, Oue A, Sadamoto T. The distribution of blood flow in the carotid and vertebral arteries during dynamic exercise in humans. J Physiol Jun 1 2011;589(Pt 11):2847–56. doi: 10.1113/jphysiol.2010.204461 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Nakano T, Tominaga R, Nagano I, Okabe H, Yasui H. Pulsatile flow enhances endothelium-derived nitric oxide release in the peripheral vasculature. Am J Physiol Heart Circ Physiol Apr 2000;278(4):H1098–104. doi: 10.1152/ajpheart.2000.278.4.H1098 [DOI] [PubMed] [Google Scholar]
  • 44.Lanzarone E, Gelmini F, Tessari M, et al. Preservation of endothelium nitric oxide release by pulsatile flow cardiopulmonary bypass when compared with continuous flow. Artif Organs Nov 2009;33(11):926–34. doi: 10.1111/j.1525-1594.2009.00888.x [DOI] [PubMed] [Google Scholar]
  • 45.Rickards CA, Tzeng YC. Arterial pressure and cerebral blood flow variability: friend or foe? A review. Front Physiol 2014;5:120. doi: 10.3389/fphys.2014.00120 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Yamamoto K, Sokabe T, Matsumoto T, et al. Impaired flow-dependent control of vascular tone and remodeling in P2X4-deficient mice. Nat Med Jan 2006;12(1):133–7. doi: 10.1038/nm1338 [DOI] [PubMed] [Google Scholar]
  • 47.Sessa WC, Pritchard K, Seyedi N, Wang J, Hintze TH. Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression. Circ Res Feb 1994;74(2):349–53. doi: 10.1161/01.res.74.2.349 [DOI] [PubMed] [Google Scholar]
  • 48.Nakagami G, Sanada H, Matsui N, et al. Effect of vibration on skin blood flow in an in vivo microcirculatory model. Biosci Trends. Dec 2007;1(3):161–6. [PubMed] [Google Scholar]
  • 49.Adams JA, Moore JE Jr., Moreno MR, Coelho J, Bassuk J, Wu D. Effects of periodic body acceleration on the in vivo vasoactive response to N-omega-nitro-L-arginine and the in vitro nitric oxide production. Ann Biomed Eng Dec 2003;31(11):1337–46. doi: 10.1114/1.1623486 [DOI] [PubMed] [Google Scholar]
  • 50.Adams JA, Bassuk J, Wu D, Grana M, Kurlansky P, Sackner MA. Periodic acceleration: effects on vasoactive, fibrinolytic, and coagulation factors. J Appl Physiol (1985) Mar 2005;98(3):1083–90. doi: 10.1152/japplphysiol.00662.2004 [DOI] [PubMed] [Google Scholar]
  • 51.Uryash A, Wu H, Bassuk J, Kurlansky P, Sackner MA, Adams JA. Low-amplitude pulses to the circulation through periodic acceleration induces endothelial-dependent vasodilatation. J Appl Physiol (1985) Jun 2009;106(6):1840–7. doi: 10.1152/japplphysiol.91612.2008 [DOI] [PubMed] [Google Scholar]
  • 52.Ichioka S, Yokogawa H, Nakagami G, Sekiya N, Sanada H. In vivo analysis of skin microcirculation and the role of nitric oxide during vibration. Ostomy Wound Manage. Sep 2011;57(9):40–7. [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

Data will be made available upon reasonable request.

RESOURCES